99.49
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $99.49, with a volume of 10.35M.
It is down -1.38% in the last 24 hours and up +3.18% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$100.88
Open:
$100.92
24h Volume:
10.35M
Relative Volume:
1.38
Market Cap:
$127.55B
Revenue:
$34.76B
Net Income/Loss:
$4.79B
P/E Ratio:
26.88
EPS:
3.7017
Net Cash Flow:
$5.21B
1W Performance:
-3.31%
1M Performance:
+3.18%
6M Performance:
+7.08%
1Y Performance:
+7.91%
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
State of New Jersey Common Pension Fund D Increases Position in Medtronic PLC $MDT - MarketBeat
Medtronic Stock: A Quiet Healthcare Giant With A Dividend Soul And A Tech Ambition Problem - AD HOC NEWS
Medtronic PLC $MDT Shares Sold by Aberdeen Group plc - MarketBeat
Can Medtronic plc (2M6) stock withstand sector downturnsWeekly Risk Report & Precise Entry and Exit Recommendations - mfd.ru
Stock Market Today, Feb. 13: Inflation Data Steadies Market and Slows AI Disruption Losses - The Motley Fool
Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery - Orthopedics This Week
Medtronic wins FDA nod for surgical robot for spine procedures - MassDevice
Medtronic FQ3 2026 earnings preview: What to expect - MSN
Medtronic (MDT) Prepares for FQ3 Earnings Amid Mixed Analyst Sen - GuruFocus
FDA Clears Medtronic's (MDT) Innovative Stealth AXiS Surgical Sy - GuruFocus
Medtronic Wins FDA Nod For Spine Surgery Tech Designed To Cut Repeat Imaging - Benzinga
Medtronic (NYSE:MDT) Earns "Overweight" Rating from Barclays - MarketBeat
Medtronic receives FDA clearance for Stealth Axis(TM) surgical system - marketscreener.com
Medtronic: Navigating Tariffs And Chinese VBP Challenges (NYSE:MDT) - Seeking Alpha
Needham Upgrades Medtronic (MDT) to Buy, Sets $121 PT on Product Launch Momentum - Insider Monkey
Medtronic's Stealth AXiS Surgical System Cleared by FDA for Spine - marketscreener.com
Medtronic Says FDA Clears Stealth AXiS Surgical System For Robotic Spine Surgery - Nasdaq
Here Are Friday’s Top Wall Street Analyst Research Calls: Airbnb, AMD, Broadcom, CrowdStrike, Dollar Tree, Medtronic, Pinterest, Rivian, Roku, Tapestry, and More - 24/7 Wall St.
How To Earn $500 A Month From Medtronic Stock Ahead Of Q3 Earnings - Benzinga
Medtronic (MDT) Receives Overweight Rating from Barclays with $1 - GuruFocus
Peering Into Medtronic PLC's Recent Short Interest - Benzinga
Wedbush Securities Inc. Grows Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Wealthfront Advisers LLC - MarketBeat
Krilogy Financial LLC Makes New $1.65 Million Investment in Medtronic PLC $MDT - MarketBeat
Stratos Wealth Partners LTD. Increases Stake in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Acquired by Illinois Municipal Retirement Fund - MarketBeat
Drake & Associates LLC Acquires Shares of 27,918 Medtronic PLC $MDT - MarketBeat
Medtronic stock slips as earnings near, even after Needham upgrade flags new launches - Bez Kabli
Medtronic to announce financial results for its third quarter of fiscal year 2026 - GuruFocus
Ahead of Medtronic (MDT) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Medtronic PLC $MDT Shares Sold by Rhumbline Advisers - MarketBeat
Medtronic PLC $MDT Shares Sold by Madison Asset Management LLC - MarketBeat
Caprock Group LLC Makes New $6.48 Million Investment in Medtronic PLC $MDT - MarketBeat
Medtronic | MDT Stock Price, Company Overview & News - Forbes
Medtronic (MDT) Projected to Post Earnings on Tuesday - MarketBeat
13,732 Shares in Medtronic PLC $MDT Acquired by Applied Finance Capital Management LLC - MarketBeat
Does Antitrust Verdict Targeting Hospital Contracts Change The Bull Case For Medtronic (MDT)? - Sahm
Medtronic plans to expand interventional cardiology portfolio with CathWorks acquisition - Today's Medical Developments
Needham Upgrades Medtronic (MDT) - Nasdaq
Medtronic (MDT) Stock Dips While Market Gains: Key Facts - Yahoo Finance Singapore
Medtronic (MDT) Rating Upgrade and Price Target Announcement by Needham | MDT Stock News - GuruFocus
Medtronic to Buy CathWorks for $585M - Orange County Business Journal
Medtronic (MDT) Receives Upgrade Amid Product Launches - GuruFocus
Strength in Cardiovascular Unit Likely to Lift MDT's Q3 Performance - Yahoo Finance
Breaking Down Medtronic: 13 Analysts Share Their Views - Benzinga
Medtronic (NYSE:MDT) Upgraded to "Buy" at Needham & Company LLC - MarketBeat
Needham Upgrades Medtronic to Buy From Hold, Sets $121 Price Target - marketscreener.com
Medtronic ordered to pay $382m in anticompetitive surgical device lawsuit - Medical Device Network
ProShare Advisors LLC Sells 85,491 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic plc (NYSE:MDT) Within s&p 500 index Medical Technology Set - Kalkine Media
Diamond Hill Capital Management Inc. Has $260.14 Million Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):